Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 vs Tegileridine for Postoperative Abdominal Surgery Pain
CTR20250471Phase 2Completed
- Sponsor
- Liaoning Hisun Pharmaceutical
- Start
- Feb 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in postoperative pain, sponsored by Liaoning Hisun Pharmaceutical. Started Feb 2025; status: completed.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20250471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250471.